Pharmacokinetic/Pharmacodynamic adequacy of novel -lactam/-lactamase inhibitors against gram-negative bacterial in critically ill patients.
发布时间：2025-04-30
点击次数：
- 发布时间：
- 2025-04-30
- 论文名称：
- Pharmacokinetic/Pharmacodynamic adequacy of novel -lactam/-lactamase inhibitors against gram-negative bacterial in critically ill patients.
- 发表刊物：
- Antibiotics
- 合写作者：
- Ruiying Han, Yalin Dong*
- 是否译文：
- 否
- 发表时间：
- 2021-08-17
- 上一条：Determining the optimal PD-1/PD-L1 inhibitors for first-line treatment of non-small-cell lung cancer with high level PD-L1 expression in China.
- 下一条：Determination of tigecycline in human lung epithelial cells and polymorphonuclear neutrophils by LC-MS/MS and its application in cellular pharmacokinetic study.